Retrospective study of topical medical treatment for glaucoma
Journal Title: Guoji Yanke Zazhi - Year 2018, Vol 18, Issue 10
Abstract
AIM:To document the change in pattern of topical anti-glaucoma medicine by retrospective analysis in the outpatient of a local tertiary eye hospital(Second People's Hospital of Foshan)in China during 2009-2016. <p>METHODS: The data of topical anti-glaucoma medications in outpatients in our hospital were collected from January 1<sup>st</sup> 2009 to December 31<sup>st</sup> 2016. These data were analyzed retrospectively. The main outcome measures were the percentages of prescriptions for all kinds of anti-glaucoma medications, the ratio of the mono-therapy and combination therapies, and the defined daily doses. <p>RESULTS: The ratio of beta-adrenergic receptor blocker declined from 81.51% in 2009 to 69.37% in 2016. The use of cholinergic agent decreased from 12.04% in 2009 to 3.78% in 2016. The prostaglandin derivatives increased from 8.40% in 2009 to 31.40% in 2016. Alpha 2 adrenergic receptor agonists increased from 0 in 2009 to 29.44% in 2016. Local carbonic anhydrase inhibitors changed slightly. The proportion of mono-therapy was reduced from 65.83% in 2009 to 46.22% in 2016. The ration of two agents combination increased from 32.49% in 2009 to 38.77% in 2016. The three medications combination was increased from 1.68% in 2009 to 12.96% in 2016. The proportion of four medications combination increased from 0 in 2009 to 1.97% in 2016, while the combined use of five drugs was an isolated case. <p>CONCLUSION: The proportion of topical anti-glaucoma agents has changed remarkably. The beta-adrenergic receptor blockers and cholinergic medications are decreasing, while the prostaglandin derivatives and alpha 2 adrenergic receptor agonists are increasing. The proportion of mono-therapy is declining, while the combined therapies are rising.
Authors and Affiliations
Shu-Ke Luo
Keywords
Related Articles
- EP ID EP547658
- DOI 10.3980/j.issn.1672-5123.2018.10.34
- Views 109
- Downloads 0
Soft corneal contact lens for postoperative comfort in patients with recurrent pterygium function
AIM:To evaluate the effect of soft contact lens on the comfort of postoperative patients with recurrent pterygium. <p>METHODS: For 100 eyes of 98 patients after recurrent pterygium excision, the conjunctival implant with...
Advance on persistent subretinal fluid after scleral buckle for rhegmatogenous retinal detachment
Delayed absorption of limited subretinal fluid occurs in some patients with rhegmatogenous retinal detachment(RRD)after scleral buckling. The macular-off patients may be effected more on visual function. The progress of...
Efficacy of Bevacizumab combined with EX-PRESS in the treatment of refractory glaucoma
AIM:To investigate the efficacy of Bevacizumab intravitreal injection combined with EX-PRESS in the treatment of refractory glaucoma. <p>METHODS: The research objects were 150 cases(150 eyes)of patients with refractory g...
Retinal morphology and expression of Bcl-2, Bax and VEGF in early diabetic rats
AIM: To investigate the expression and significance of B-cell lymphoma factor(Bcl-2), Bcl2-Associated X protein(BAX)and vascular endothelial growth factor(VEGF)in the retina of early diabetic rats. <p>METHODS: An early d...
Efficacy at early stage after FS-LASIK with accelerated corneal collagen cross-linking
AIM:To evaluate the safety and efficacy at early stage after femtosecond laser-assisted excimer laser <i>in situ</i> keratomileusis(FS-LASIK)combined with collagen cross-linking. <p>METHODS: Totally 30 myopia patients(60...